114 related articles for article (PubMed ID: 10952089)
1. A novel computational method for predicting the transmembrane structure of G-protein coupled receptors: application to human C5aR and C3aR.
Rayan A; Siew N; Cherno-Schwartz S; Matzner Y; Bautsch W; Goldblum A
Recept Channels; 2000; 7(2):121-37. PubMed ID: 10952089
[TBL] [Abstract][Full Text] [Related]
2. C5a receptor activation. Genetic identification of critical residues in four transmembrane helices.
Baranski TJ; Herzmark P; Lichtarge O; Gerber BO; Trueheart J; Meng EC; Iiri T; Sheikh SP; Bourne HR
J Biol Chem; 1999 May; 274(22):15757-65. PubMed ID: 10336477
[TBL] [Abstract][Full Text] [Related]
3. Genetic mapping of the human C5a receptor. Identification of transmembrane amino acids critical for receptor function.
Geva A; Lassere TB; Lichtarge O; Pollitt SK; Baranski TJ
J Biol Chem; 2000 Nov; 275(45):35393-401. PubMed ID: 10952985
[TBL] [Abstract][Full Text] [Related]
4. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W
Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370
[TBL] [Abstract][Full Text] [Related]
5. Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.
Chen Z; Zhang X; Gonnella NC; Pellas TC; Boyar WC; Ni F
J Biol Chem; 1998 Apr; 273(17):10411-9. PubMed ID: 9553099
[TBL] [Abstract][Full Text] [Related]
6. Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor.
Sun J; Ember JA; Chao TH; Fukuoka Y; Ye RD; Hugli TE
Protein Sci; 1999 Nov; 8(11):2304-11. PubMed ID: 10595533
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation.
Fukuoka Y; Ember JA; Hugli TE
Biochem Biophys Res Commun; 1998 Jan; 242(3):663-8. PubMed ID: 9464274
[TBL] [Abstract][Full Text] [Related]
8. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.
Monk PN; Barker MD; Partridge LJ; Pease JE
J Biol Chem; 1995 Jul; 270(28):16625-9. PubMed ID: 7622471
[TBL] [Abstract][Full Text] [Related]
9. Modeling of G-protein coupled receptors with bacteriorhodopsin as a template. A novel approach based on interaction energy differences.
Röper D; Jacoby E; Krüger P; Engels M; Grötzinger J; Wollmer A; Strassburger W
J Recept Res; 1994 May; 14(3-4):167-86. PubMed ID: 8083862
[TBL] [Abstract][Full Text] [Related]
10. Role of the second extracellular loop of human C3a receptor in agonist binding and receptor function.
Chao TH; Ember JA; Wang M; Bayon Y; Hugli TE; Ye RD
J Biol Chem; 1999 Apr; 274(14):9721-8. PubMed ID: 10092660
[TBL] [Abstract][Full Text] [Related]
11. C5a receptor oligomerization. I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor.
Klco JM; Lassere TB; Baranski TJ
J Biol Chem; 2003 Sep; 278(37):35345-53. PubMed ID: 12835319
[TBL] [Abstract][Full Text] [Related]
12. Ligand-induced phosphorylation of anaphylatoxin receptors C3aR and C5aR is mediated by "G protein-coupled receptor kinases.
Langkabel P; Zwirner J; Oppermann M
Eur J Immunol; 1999 Sep; 29(9):3035-46. PubMed ID: 10508278
[TBL] [Abstract][Full Text] [Related]
13. On the use of the transmembrane domain of bacteriorhodopsin as a template for modeling the three-dimensional structure of guanine nucleotide-binding regulatory protein-coupled receptors.
Pardo L; Ballesteros JA; Osman R; Weinstein H
Proc Natl Acad Sci U S A; 1992 May; 89(9):4009-12. PubMed ID: 1315046
[TBL] [Abstract][Full Text] [Related]
14. Structural mechanisms of constitutive activation in the C5a receptors with mutations in the extracellular loops: molecular modeling study.
Nikiforovich GV; Baranski TJ
Proteins; 2012 Jan; 80(1):71-80. PubMed ID: 21960464
[TBL] [Abstract][Full Text] [Related]
15. Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking.
Hagemann IS; Narzinski KD; Floyd DH; Baranski TJ
J Biol Chem; 2006 Dec; 281(48):36783-92. PubMed ID: 17023413
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of an isolated helical capping box in solution by hydrophobic interactions: evidence from the NMR study of bioactive peptides from the C-terminus of human C5a anaphylatoxin.
Ni F; Carpenter KA; Ripoll DR; Sanderson SD; Hugli TE
Biopolymers; 1996 Jan; 38(1):31-41. PubMed ID: 8679942
[TBL] [Abstract][Full Text] [Related]
17. BUNDLE: a program for building the transmembrane domains of G-protein-coupled receptors.
Filizola M; Perez JJ; Cartenì-Farina M
J Comput Aided Mol Des; 1998 Mar; 12(2):111-8. PubMed ID: 9690171
[TBL] [Abstract][Full Text] [Related]
18. Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding.
Zhang X; Boyar W; Galakatos N; Gonnella NC
Protein Sci; 1997 Jan; 6(1):65-72. PubMed ID: 9007977
[TBL] [Abstract][Full Text] [Related]
19. C5a receptor oligomerization. II. Fluorescence resonance energy transfer studies of a human G protein-coupled receptor expressed in yeast.
Floyd DH; Geva A; Bruinsma SP; Overton MC; Blumer KJ; Baranski TJ
J Biol Chem; 2003 Sep; 278(37):35354-61. PubMed ID: 12835318
[TBL] [Abstract][Full Text] [Related]
20. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
